Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA:600329)

SHA:600329 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	26,655	20,699	22,121	18,246	19,473	11,199
Market Cap Growth	10.59%	-6.43%	21.24%	-6.30%	73.88%	23.50%
Enterprise Value	25,261	20,519	20,903	16,178	17,504	9,587
Last Close Price	39.80	29.64	31.14	26.35	27.80	15.30
PE Ratio	13.80	9.29	22.42	21.17	25.32	16.93
Forward PE	36.85	22.87	22.87	22.87	22.87	16.30
PS Ratio	3.99	2.83	2.69	2.21	2.82	1.70
PB Ratio	3.24	2.64	3.33	2.79	2.99	1.88
P/TBV Ratio	3.37	2.75	3.56	2.96	3.16	2.00
P/FCF Ratio	21.46	25.65	40.40	32.05	28.00	23.22
P/OCF Ratio	19.46	22.39	32.13	26.94	22.85	16.68
EV/Sales Ratio	3.78	2.81	2.54	1.96	2.53	1.45
EV/EBITDA Ratio	27.33	22.97	22.06	20.58	24.96	14.51
EV/EBIT Ratio	31.47	26.51	25.46	24.10	29.82	17.40
EV/FCF Ratio	20.34	25.43	38.17	28.42	25.17	19.88
Debt / Equity Ratio	0.01	0.01	0.05	0.04	0.01	0.01
Debt / EBITDA Ratio	0.09	0.04	0.36	0.34	0.06	0.06
Debt / FCF Ratio	0.06	0.05	0.62	0.47	0.06	0.09
Asset Turnover	-	0.70	0.81	0.86	0.80	0.82
Inventory Turnover	-	2.67	3.09	3.38	2.76	2.61
Quick Ratio	1.12	1.87	1.51	1.71	1.81	1.85
Current Ratio	2.00	2.35	2.03	2.17	2.64	2.59
Return on Equity (ROE)	29.64%	30.56%	14.68%	13.37%	12.63%	11.85%
Return on Assets (ROA)	-	4.61%	5.03%	4.37%	4.23%	4.27%
Return on Capital (ROIC)	6.56%	6.50%	7.43%	6.27%	5.85%	5.96%
Return on Capital Employed (ROCE)	9.60%	9.70%	11.70%	9.80%	8.90%	9.00%
Earnings Yield	8.31%	10.77%	4.46%	4.72%	3.95%	5.91%
FCF Yield	4.66%	3.90%	2.48%	3.12%	3.57%	4.31%
Dividend Yield	3.13%	4.32%	4.11%	4.25%	1.80%	1.96%
Payout Ratio	45.50%	45.33%	88.91%	44.96%	30.17%	35.15%
Buyback Yield / Dilution	0.41%	-0.07%	0.71%	-0.94%	0.04%	0.37%
Total Shareholder Return	3.59%	4.25%	4.82%	3.31%	1.83%	2.33%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.